Study's Care of Acute Pancreatitis at Saint-Etienne University Hospital.
1 other identifier
observational
140
1 country
1
Brief Summary
Internal medicine units treat patients with undifferentiated or multisystem diseases, with a non-specific organ approach. In some cases, patients with single-organ disease may be admitted to internal medicine wards. Acute pancreatitis is the most common gastrointestinal illness requiring acute admission to hospital. It is characterised by local and systemic inflammation of the pancreas corresponding to single-organ disease. For patients with single-organ disease such as acute pancreatitis, it is not known whether admission to internal medicine is as effective as admission to a unit specialising in a specific organ, such as hepato-gastro-enterology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 6, 2024
CompletedFirst Submitted
Initial submission to the registry
September 10, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedSeptember 19, 2024
June 1, 2024
10 months
September 10, 2024
September 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Performance Stay Length Index
"Performance Stay Length Index", is a measure used to evaluate the efficiency of hospital care in terms of patients' length of stay. This index is calculated by comparing the average length of stay of patients in a given service to a predefined reference, often based on established standards or goals.
From the date of inclusion to the date of discharge from hospital, assessed for up to 100 months
Secondary Outcomes (2)
Rate of complications at 1 year
During one year from diagnosis
Rate of rehospitalization at 1 year
During one year from diagnosis
Study Arms (2)
The Internal Medicine Unit arm
It includes all patients hospitalized in the Internal Medicine Unit. Patients may have been previously hospitalized in the emergency department or in another department such as intensive care.
The hepato-gastro-enterology Unit arm
It includes all patients hospitalized in the Gastroenterology unit. Patients may have been previously hospitalized in the emergency department or in another department such as intensive care.
Interventions
Data collected: Socio-demographic, hospital, clinical, biological, and imaging data
Eligibility Criteria
All adult patients hospitalized from January 1, 2022, to December 31, 2023 in the University Hospital of Saint Etienne with a primary diagnosis of acute pancreatitis in Internal Medicine and gastroenterology will be included.
You may qualify if:
- adult patient
- primary diagnosis of acute pancreatitis in Internal Medicine and gastroenterology.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Saint-Etienne
Saint-Etienne, 42055, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kyria REGALADE, resident
CHU SAINT-ETIENNE
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2024
First Posted
September 19, 2024
Study Start
June 6, 2024
Primary Completion
April 1, 2025
Study Completion
April 1, 2025
Last Updated
September 19, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share